227 related articles for article (PubMed ID: 29126399)
1. Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
Kazaks A; Lu IN; Farinelle S; Ramirez A; Crescente V; Blaha B; Ogonah O; Mukhopadhyay T; de Obanos MP; Krimer A; Akopjana I; Bogans J; Ose V; Kirsteina A; Kazaka T; Stonehouse NJ; Rowlands DJ; Muller CP; Tars K; Rosenberg WM
BMC Biotechnol; 2017 Nov; 17(1):79. PubMed ID: 29126399
[TBL] [Abstract][Full Text] [Related]
2. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
Zheng D; Chen S; Qu D; Chen J; Wang F; Zhang R; Chen Z
Vaccine; 2016 Dec; 34(51):6464-6471. PubMed ID: 27866773
[TBL] [Abstract][Full Text] [Related]
3. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
Chen S; Zheng D; Li C; Zhang W; Xu W; Liu X; Fang F; Chen Z
Biomed Res Int; 2015; 2015():901817. PubMed ID: 25767809
[TBL] [Abstract][Full Text] [Related]
4. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
[TBL] [Abstract][Full Text] [Related]
6. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
7. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
10. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.
Blokhina EA; Kuprianov VV; Stepanova LA; Tsybalova LM; Kiselev OI; Ravin NV; Skryabin KG
Virology; 2013 Jan; 435(2):293-300. PubMed ID: 23062739
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
12. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
[TBL] [Abstract][Full Text] [Related]
15. The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
Sheng Y; Li Z; Lin X; Ma Y; Ren Y; Su Z; Ma G; Zhang S
Vaccine; 2023 Jul; 41(33):4867-4878. PubMed ID: 37391312
[TBL] [Abstract][Full Text] [Related]
16. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
[TBL] [Abstract][Full Text] [Related]
17. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
Sominskaya I; Skrastina D; Dislers A; Vasiljev D; Mihailova M; Ose V; Dreilina D; Pumpens P
Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
[TBL] [Abstract][Full Text] [Related]
18. Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.
Thompson CM; Petiot E; Mullick A; Aucoin MG; Henry O; Kamen AA
BMC Biotechnol; 2015 May; 15():31. PubMed ID: 25981500
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
